Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
 |
Food and Drug Administration - May 26, 2006
Richard Klein, HIV/AIDS Program Director
Wednesday, May 31, 2006
The Forum for Collaborative HIV Research and the FDA's Division of Antiviral Products will host an open public meeting on May 31, 2006 to discuss issues regarding the development of CCR5 co-receptor antagonists for the treatment of HIV infection. Specific issues for discussion are mechanisms for long-term follow-up to monitor safety of patients enrolled in CCR5 antagonist clinical trials, potential consequences of viral tropism changes, and characterization of resistance to these investigational agents.
WEBCAST INFORMATION FOR THOSE NOT ABLE TO ATTEND IN PERSON:
Free Webcast Set-up:
Please click on this link: Click Me
Scroll down to the bottom of the page and login or become a member.
Once you log in or become a member of FDALive.com on the home page you will see and click Upcoming Webcast.
Under Upcoming Webcast you will see the meeting of interest on the same line item click Order Webcast.
Put a Check in the webcast order for $0.00 and Add Items to Cart Above.
Next Click on Checkout.
Scroll down to bottom of page and purchase meeting on account number: 053106 - then continue.
On next page scroll down to bottom one last time and click Process Order.
Once order goes thru on the next page you will continue to My Account.
You will find the link to the meeting on the homepage or in My Account Area
(Before the meeting the link will state PENDING and on the day of the meeting the link will state VIEW WEBCAST>
If you have any problems or need help: please call us at 301.984.0001 or email: support@FDALive.com
**The webcast will be accessible up to one year after the meeting for future reference**
FOR THOSE WHO ARE ABLE TO ATTEND IN PERSON:
The meeting will be held from 8:30am - 4:15pm in the Continental Ballroom and Amphitheater on the 3rd floor of The George Washington University Marvin Center (The Marvin Center, 800 21st Street, N.W., Washington, DC 20052). For information regarding directions, parking, etc. please go to http://gwired.gwu.edu/marvincenter/info/Address/.
The final agenda and a list of Background Documents are available on the Forum's website at http://www.hivforum.org/. We will have a limited number of copies at the meeting so we would prefer participants to view the documents beforehand or to make their own copies if possible.
Registration/check-in will begin at 8:00 am outside of the Continental Ballroom. We will also have an overflow room (Amphitheater-next to Continental Ballroom) which will allow those who are not able to sit inside the Continental Ballroom to view the meeting via webcast.
Lunch will not be provided; however, there are plenty of area restaurants/eateries that you can walk to. Across from the Marvin Center, the shops at 2000 Penn offer a variety of places to eat.
Please visit their website for ideas -
http://www.2000penn.com/wheretoeat.html. Lunch will be from 12:30 - 1:30pm.
If you should have any questions pertaining to the meeting on the 31st, please contact Becky Griesse at blg@gwu.edu or at 202-416-0494.
Richard Klein
HIV/AIDS Program Director
Office of Special Health Issues
Food and Drug Administration
060526
FD060504
SOURCE: Food and Drug Administration (FDA).
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .